StudyFinder
Search Results
1 Study Matches
Exploratory Trial of Ruxolitinib 1.5% Cream for Early Stage Hidradenitis Suppurativa
Explore all stages of Hidradenitis Suppurativa with a topical medication.
There will be 7 in-person visits and 1 follow-up phone call over a 33 week period. Over the course of the study, the following study procedures will take place: medical history and medication history collection, ECG, lab tests (both blood and urine), photography, skin exams, physical exams, questionnaires, and skin biopsies.
Up to $350
Amy Longenecker - at alongenecker@pennstatehealth.psu.edu or 717-531-5136
All
18 year(s) or older
NCT04414514
STUDY00016042
Inclusion Criteria:
Must have diagnosis of HS for at least 3 months (90 days)Must have active HS in at least 1 area
Must have negative TB screening assessment
Certain medications can be continued if on stable dose; study coordinator will discuss further.
Exclusion Criteria:
Any other active skin disease or condition that may interfere with assessment of HSPregnant (or considering becoming pregnant) or lactating females
Does not have reliable internet access for weekly electronic surveys
Skin Conditions
Prefer not to display